Instrument Inactif

Communiqués Stereotaxis Inc OTC Bulletin Board

Actions

Equipement et technologie médicale avancés

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

15/07	Stereotaxis dépose un projet d'enregistrement pour la revente de 108,9 millions d'actions	MT
07/07	Stereotaxis, Inc. (NYSEAM:STXS) a finalisé l'acquisition de Robocath SAS.	CI

Communiqués

09/07	Stereotaxis Completes Acquisition of Robocath	AQ
12/05	Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates	AQ
22/04	Stereotaxis Announces First MAGiC Procedures in the United States	AQ
21/04	Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026	AQ
15/04	Stereotaxis Announces Definitive Agreement to Acquire Robocath	AQ
06/04	Stereotaxis Announces FDA Clearance and Launch of Synchrony System	AQ
09/03	Stereotaxis Reports 2025 Full Year Financial Results	AQ
12/02	Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026	AQ
09/02	Klinikum Fürth Establishes Leading Robotic Heart Arrhythmia Program	AQ
06/01	Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter	AQ
24/11	Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference	AQ
11/11	Stereotaxis Reports 2025 Third Quarter Financial Results	AQ
10/11	GenesisX Robotic Magnetic Navigation System Receives U.S. FDA Clearance	AQ
21/10/25	Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025	AQ
15/10/25	Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs	AQ
13/10/25	Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias	AQ
23/09/25	Stereotaxis - Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System	AQ
22/09/25	Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System	AQ
02/09/25	First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter	AQ
02/09/25	Stereotaxis to Present at Upcoming Investor Conferences	AQ
28/08/25	Stereotaxis Technology to be Featured at Heart Rhythm Society’s HRX 2025	AQ
07/08/25	Stereotaxis Reports 2025 Second Quarter Financial Results	AQ
28/07/25	Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter	AQ
23/07/25	Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025	AQ
17/07/25	Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock	AQ